Skip to main content
. 2019 Jan 3;24(5):596–601. doi: 10.1007/s10147-018-01385-8

Table 3.

Summary of chemoherapeutic response as assessed by RECIST criteria

Response No. of cases (%), n = 103
CR 19 (18.4)
PR 29 (28.2)
SD 23 (22.3)
Subtotal 71 (69.1)
 PD 32 (30.9)

CR complete response, PR partial response, SD stable disease, PD progressive disease